Article archive
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Research by the University of Salford, University of Manchester and prosthetics company Blatchford’s Endolite Technology Centre will help to enhance the mobility of people with above-knee amputations by improving the energy efficiency of prosthetic legs.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Scientists at the University of Glasgow have developed a new method to make packaged food safer for consumers and more long-lived on the shelf by harnessing the germ-killing power of ozone.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Recipharm and PledPharma announce FDA approval of an IND application for Phase IIb clinical trial with PledOx, PLIANT, in the U.S.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Physicists of the University of Vienna together with researchers from the University of Natural Resources and Life Sciences Vienna developed nano-machines which recreate principal activities of proteins.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
The hunt for new life-saving antibiotics is taking researchers to some of the deepest and coldest places on Earth. Led by the University of Aberdeen, scientists from across Europe will probe previously untapped oceanic trenches in the Arctic and Antarctic to collect and screen samples of mud and sediment.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Almac, leading provider of contract services to the global Pharmaceutical and Biotech industries, will play a key role in delivering industry insight on the topic of Supply Chain Management at this year’s 14th Annual CTS Europe event, taking place 26-27th February in Berlin.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
A single embryonic stem cell can develop into more than 200 specialized cell types that make up our body. This maturation process is called differentiation and is tightly regulated through strict control of gene activity.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Aesica and EmulTech jointly announce the commercial development of ET4ME - an innovative emulsion technology for product formulation.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Porvair Sciences has announced a new range of 12-, 24-, 48- and 96 well format untreated polystyrene culture microplates for growing cells in stationary suspension or other applications where reduced cell attachment is desired.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Leading the way in gas generation for over a decade, Peak Scientific have expertly designed a new system solution that can be tailored to any GC laboratory’s needs.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
This event will gather over 85 leading logistics and cold chain experts from big pharma companies, wholesalers, retailers and associations on 9 -10 April 2013 in Vienna, Austria.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
A lack of the protein endoglin in the blood vessels of tumour-bearing mice enables the spread of daughter tumours, according to researchers at Karolinska Institutet and Lund University, Sweden.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Scientists at the University of Sheffield are fighting an incurable type of cancer with a pioneering new approach which could not only halt devastating bone damage, but also repair it.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
ProtAffin AG has announced that a collaboration with a leading European centre for the study of cystic fibrosis has generated promising pre-clinical results for the company’s lead anti-inflammatory product, PA401.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Scientists have identified the molecular system that contributes to the harmful inflammatory reaction in the brain during neurodegenerative diseases.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
A project to drive forward the understanding of key biological processes by developing new microscope technologies has received a £2m funding boost. The new technologies will allow researchers to answer previously inaccessible questions related to cell biology, cancer, learning and memory, and molecular/cellular microbiology.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Bone Therapeutics, the leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, announces that it has secured its future manufacturing requirements, allowing it to produce its unique bone cell therapy products on a commercial scale.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
Study reveals how people with a severe unexplained psychological illness have abnormal activity in the brain - New research from the University of Cambridge and UCL suggests that individuals with psychogenic disease, that is to say physical illness that stems from emotional or mental stresses, do have brains that function differently.
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
BioCellChallenge SAS, a biotechnology firm specialized in the creation and development of delivery systems for introducing active principles into live cells, has announced the launch of a new delivery system, ImmunoCellin, which is designed to transport antibodies into live cells even in the presence of additives
Submitted by Anonymous (not verified) on Mon, 03/04/2013 - 23:21
New research led by the University of York will carry out a detailed appraisal of Drug Recovery Wings which have been established in 11 prisons in England and Wales.
Pages